Clinical Trials Browser

Phase 1 × Melanoma × DS-8273a × Clear all

NCT02983006 2021-10-18

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Phase 1 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma